List of works - Che C Colpitts

5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza virus, hepatitis C virus, and other enveloped viruses

scientific article published on 2 January 2013

A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factor

scientific article published on 01 June 2020

A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans

scientific article published on 30 April 2014

A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses.

scientific article published on 29 July 2015

Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing properties

scientific article published on 23 May 2015

Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure

scientific article published on 16 August 2016

Cell Culture Models for the Investigation of Hepatitis B and D Virus Infection

scientific article published on 20 September 2016

Claudins and pathogenesis of viral infection

scientific article published on 07 May 2015

Claudins in viral infection: from entry to spread

scientific article published on 24 November 2016

Entry Inhibitors: A Perspective for Prevention of Hepatitis C Virus Infection in Organ Transplantation.

scientific article published on 16 August 2017

Genome-wide analysis of the chalcone synthase superfamily genes of Physcomitrella patens

scientific article published on 31 October 2009

Hepatitis B virus receptors and molecular drug targets.

scientific article published on 15 March 2016

Hepatitis C Virus Entry: An Intriguingly Complex and Highly Regulated Process

scientific article published on 18 March 2020

Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.

scientific article

Hepatitis C virus exploits cyclophilin A to evade PKR

scientific article published on 16 June 2020

Hepatitis C virus vaccine candidates inducing protective neutralizing antibodies

scientific article

High-throughput approaches to unravel hepatitis C virus-host interactions

scientific article published on 24 September 2015

Host cell kinases and the hepatitis C virus life cycle.

scientific article published on 18 April 2015

Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape

scientific article published on 30 March 2017

Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation

scientific article

LAP6/POLYKETIDE SYNTHASE A and LAP5/POLYKETIDE SYNTHASE B encode hydroxyalkyl α-pyrone synthases required for pollen development and sporopollenin biosynthesis in Arabidopsis thaliana.

scientific article published on 30 December 2010

Multifaceted role of E-cadherin in hepatitis C virus infection and pathogenesis.

scientific article published on 24 June 2016

Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry

scientific article published on 15 September 2017

Physcomitrella PpORS, basal to plant type III polyketide synthases in phylogenetic trees, is a very long chain 2'-oxoalkylresorcinol synthase.

scientific article published on 7 December 2012

Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses

scientific article

SCARB1 variants and HCV infection: Host susceptibility is lost in translation

scientific article

SMAD About Hepatitis C Virus Cell Entry and Liver Disease

scientific article published on 23 November 2016

Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes ⬇️

scientific article (publication date: 25 October 2016)

Targeting Viral Entry for Treatment of Hepatitis B and C Virus Infections

scientific article published on 18 May 2015

The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry

scientific article

Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells

scientific article published on July 2014

Viral hepatitis: A new HCV cell culture model for the next clinical challenges

scientific article published on 6 October 2015

When one receptor closes, another opens: claudins and the hepatitis C virus E1 glycoprotein.

scientific article published on 30 April 2015

List of works by Che C Colpitts

5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza virus, hepatitis C virus, and other enveloped viruses

A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factor

A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans

A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses.

Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing properties

Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure

Cell Culture Models for the Investigation of Hepatitis B and D Virus Infection

Claudins and pathogenesis of viral infection

Claudins in viral infection: from entry to spread

Entry Inhibitors: A Perspective for Prevention of Hepatitis C Virus Infection in Organ Transplantation.

Genome-wide analysis of the chalcone synthase superfamily genes of Physcomitrella patens

Hepatitis B virus receptors and molecular drug targets.

Hepatitis C Virus Entry: An Intriguingly Complex and Highly Regulated Process

Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.

Hepatitis C virus exploits cyclophilin A to evade PKR

Hepatitis C virus vaccine candidates inducing protective neutralizing antibodies

High-throughput approaches to unravel hepatitis C virus-host interactions

Host cell kinases and the hepatitis C virus life cycle.

Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape

Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation

LAP6/POLYKETIDE SYNTHASE A and LAP5/POLYKETIDE SYNTHASE B encode hydroxyalkyl α-pyrone synthases required for pollen development and sporopollenin biosynthesis in Arabidopsis thaliana.

Multifaceted role of E-cadherin in hepatitis C virus infection and pathogenesis.

Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry

Physcomitrella PpORS, basal to plant type III polyketide synthases in phylogenetic trees, is a very long chain 2'-oxoalkylresorcinol synthase.

Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses

SCARB1 variants and HCV infection: Host susceptibility is lost in translation

SMAD About Hepatitis C Virus Cell Entry and Liver Disease

Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes ⬇️

Targeting Viral Entry for Treatment of Hepatitis B and C Virus Infections

The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry

Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells

Viral hepatitis: A new HCV cell culture model for the next clinical challenges

When one receptor closes, another opens: claudins and the hepatitis C virus E1 glycoprotein.